136 related articles for article (PubMed ID: 33631754)
1. Antibiotics Removal by Continuous Venovenous Hemofiltration with a Novel Asymmetric Triacetate Membrane Hemofilter: An in vitro Study.
Körtge A; Majcher-Peszynska J; Heskamp B; Wasserkort R; Mitzner S
Blood Purif; 2021; 50(6):899-905. PubMed ID: 33631754
[TBL] [Abstract][Full Text] [Related]
2. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis.
Joy MS; Matzke GR; Frye RF; Palevsky PM
Am J Kidney Dis; 1998 Jun; 31(6):1019-27. PubMed ID: 9631848
[TBL] [Abstract][Full Text] [Related]
3. Thrombogenicity and long-term cytokine removal capability of a novel asymmetric triacetate membrane hemofilter.
Körtge A; Wild T; Heskamp B; Folk M; Mitzner S; Wasserkort R
J Artif Organs; 2018 Dec; 21(4):435-442. PubMed ID: 30039457
[TBL] [Abstract][Full Text] [Related]
4. Daptomycin elimination by CVVH in vitro: evaluation of factors influencing sieving and membrane adsorption.
Wagner CC; Steiner I; Zeitlinger M
Int J Clin Pharmacol Ther; 2009 Mar; 47(3):178-86. PubMed ID: 19281727
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin clearance during modeled continuous renal replacement therapy.
Churchwell MD; Pasko DA; Mueller BA
Blood Purif; 2006; 24(5-6):548-54. PubMed ID: 17124423
[TBL] [Abstract][Full Text] [Related]
6. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
[TBL] [Abstract][Full Text] [Related]
7. Comparison of adsorption of selected antibiotics on the filters in continuous renal replacement therapy circuits: in vitro studies.
Onichimowski D; Ziółkowski H; Nosek K; Jaroszewski J; Rypulak E; Czuczwar M
J Artif Organs; 2020 Jun; 23(2):163-170. PubMed ID: 31630269
[TBL] [Abstract][Full Text] [Related]
8. Myoglobin clearance and removal during continuous venovenous hemofiltration.
Amyot SL; Leblanc M; Thibeault Y; Geadah D; Cardinal J
Intensive Care Med; 1999 Oct; 25(10):1169-72. PubMed ID: 10551978
[TBL] [Abstract][Full Text] [Related]
9. Removal of 17 cytokines, HMGB1, and albumin by continuous hemofiltration using a cellulose triacetate membrane: an ex vivo study.
Yasuda N; Goto K; Yamamoto S; Hidaka S; Hagiwara S; Noguchi T
J Surg Res; 2012 Jul; 176(1):226-31. PubMed ID: 22099603
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin removal and pharmacokinetics during accelerated venovenous hemofiltration.
Lopez ND; Griggs M; Sin JH; Roberts RJ; Allegretti AS
Pharmacotherapy; 2024 Jan; 44(1):69-76. PubMed ID: 37798109
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of and maintenance dose recommendations for vancomycin in severe pneumonia patients undergoing continuous venovenous hemofiltration with the combination of predilution and postdilution.
Li Q; Liang F; Sang L; Li P; Lv B; Tan L; Liu X; Chen W
Eur J Clin Pharmacol; 2020 Feb; 76(2):211-217. PubMed ID: 31734748
[TBL] [Abstract][Full Text] [Related]
15. Cytokine removal with a large pore cellulose triacetate filter: an ex vivo study.
Uchino S; Bellomo R; Goldsmith D; Davenport P; Cole L; Baldwin I; Panagiotopoulos S; Tipping F; Ronco C; Everard P
Int J Artif Organs; 2002 Jan; 25(1):27-32. PubMed ID: 11853067
[TBL] [Abstract][Full Text] [Related]
16. Can we use an ex vivo continuous hemofiltration model to describe the adsorption and elimination of meropenem and piperacillin?
Jamal JA; Udy AA; Wallis SC; Ranganathan D; McWhinney BC; Ungerer JP; Lipman J; Roberts JA
Int J Artif Organs; 2015 Aug; 38(8):419-24. PubMed ID: 26349527
[TBL] [Abstract][Full Text] [Related]
17. Super high flux hemofiltration: a new technique for cytokine removal.
Uchino S; Bellomo R; Goldsmith D; Davenport P; Cole L; Baldwin I; Panagiotopoulos S; Tipping P
Intensive Care Med; 2002 May; 28(5):651-5. PubMed ID: 12029417
[TBL] [Abstract][Full Text] [Related]
18. Adsorption of vancomycin, gentamycin, ciprofloxacin and tygecycline on the filters in continuous renal replacement therapy circuits: in full blood in vitro study.
Onichimowski D; Nosek K; Ziółkowski H; Jaroszewski J; Pawlos A; Czuczwar M
J Artif Organs; 2021 Mar; 24(1):65-73. PubMed ID: 33033945
[TBL] [Abstract][Full Text] [Related]
19.
Sime FB; Pandey S; Karamujic N; Parker S; Alexander E; Loutit J; Durso S; Griffith D; Lipman J; Wallis SC; Roberts JA
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082292
[TBL] [Abstract][Full Text] [Related]
20. In vitro Evaluation of Linezolid and Doripenem Clearance with Different Hemofilters.
Hiraiwa T; Moriyama K; Matsumoto K; Shimomura Y; Kato Y; Yamashita C; Hara Y; Kawaji T; Kurimoto Y; Nakamura T; Kuriyama N; Shibata J; Komura H; Morita K; Nishida O
Blood Purif; 2020; 49(3):295-301. PubMed ID: 31995801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
